Buy or sell Genapsys stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

View More Companies

Genapsys Stock

GenapSys develops DNA sequencing technologies and systems for applied genomic testing and medical sequencing.

Founded

2010

Notable Investors

Headquarters

Total Funding

$45.5M

About Genapsys Stock

GenapSys, Inc. is committed to a new era of applied genomic testing and a new paradigm for medical sequencing. We are developing a cost-disruptive, easy-to-use genomic diagnostic system based on our simple label-free proprietary GENIUS™ technology which delivers 100x improvement in cost and speed. These innovations will enable a new era of medicine through the widespread acquisition of genomic data for research and testing of genetic disease, cancer, and microbes.

Funding History

May 2012	$0
March 2013	$8.5M
November 2013	$37.0M

Management

Head of Talent & Happiness

Diana Kofman

Director of Nanofabrication

Kosar Parizi

Director of Business Development

Avaleigh Milne

Senior Director & Head of Europe

Leila Zegna

Director of Sequencing

Xavier Gomes

Leads Strategic Initiatives

Howard Goldstein

VP of Product Development

Subra Sankar

VP Engineering

Hamid Rategh

Director of Product & Test Engineering

Ashok Ramachandran

Director of Chemistry

Aldrich Lau

Press

Funding Daily: Busy little bees | VentureBeat | Deals | by Rebecca Grant

- Nov, 14 2013

Genapsys raises $8.5M to sequence your genome on a cheap chip

- Mar, 26 2013

Inside StartX Stanford’s Spring 2012 Demo Day [TCTV]

- Jun, 2 2012

Other Companies

Atreca

Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.

Learn More

BRAIN

BRAIN provides biodiversity-based solutions for applications in the chemical, pharmaceutical, cosmetics and food industries.

Learn More

Chrome River Technologies

Provider of expense reporting and invoice management

Learn More

Palantir Technologies

Big Data Analytics and Visualization

Learn More

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Genapsys or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.